GrandeLASH-MD, GrandeBROW, and GrandeHAIR Serums
Allegations: Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow…
Nixon et al. v. Grande Cosmetics, LLC
22-cv-6639, D.N.J.
(Nov. 2022)
Grande cosmetics, including GrandeLASH-MD Lash Enhancing Serum, GrandeBROW Brow Enhancing Serum, and GrandeHAIR Enhancement Serum
Failing to disclose that products contain an active ingredient found in prescription drugs (isopropyl cloprostenate), which may cause serious side effects and which the FDA has only approved for use under the supervision of a doctor
Settled
(Preliminarily approved)
Allegations: Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow…
Allegations: Misleadingly marketing products as safe cosmetics when they are actually drugs that contain an ingredient that poses serious health risks
Common ingredient raises potential health risks not always clearly disclosed in the marketing.